Sana Biotechnology SANA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $123.51M-37.1% | $131.98M-38.8% | $142.2M-37.2% | $165.3M-30.8% | $196.41M-21.8% | ||
| $44.27M-25.3% | $44.3M-30.8% | $49.39M-26.9% | $53.15M-26.9% | $59.26M-18.6% | ||
| $248.3M+16.8% | $250.32M-8.2% | $239.99M-23.2% | $258.23M+2.1% | $212.63M-33.5% | ||
| $248.3M+16.8% | $250.32M-8.2% | $239.99M-23.2% | $258.23M+2.1% | $212.63M-33.5% | ||
| -$248.3M-16.8% | -$250.32M+8.2% | -$239.99M+23.2% | -$258.23M-2.1% | -$212.63M+33.5% | ||
| $3.81M-54.8% | $3.85M-63.3% | $4.23M-63.4% | $5.8M-50.9% | $8.43M-23.3% | ||
| $2.51M+154% | $2.31M+150% | $1.21M+125% | $105K+103% | -$4.61M-2,297% | ||
| -$241.99M-16.0% | -$244.17M+8.5% | -$234.41M+23.3% | -$252.18M-3.0% | -$208.67M+32.4% | ||
| -$0.93-5.7% | -$0.97+16.4% | -$0.97+30.7% | -$1.06+7.8% | -$0.88+42.5% | ||
| -$0.93-5.7% | -$0.97+16.4% | -$0.97+30.7% | -$1.06+7.8% | -$0.88+42.5% | ||
| 1B+9.7% | 989.7M+7.8% | 967.4M+9.7% | 942.3M+11.3% | 938.3M+16.6% | ||
| 1B+9.7% | 989.7M+7.8% | 967.4M+9.7% | 942.3M+11.7% | 938.3M+17.1% | ||
| $3.81M-54.8% | $3.85M-63.3% | $4.23M-63.4% | $5.8M-50.9% | $8.43M-23.3% | ||
| $2.51M+154% | $2.31M+150% | $1.21M+125% | $105K+103% | -$4.61M-2,297% | ||
| $35.91M+180% | $29.43M+431% | $1.9M— | -$6.73M— | -$44.93M— | ||
| -$248.3M-16.8% | -$250.32M+8.2% | -$239.99M+23.2% | -$258.23M-2.1% | -$212.63M+33.5% | ||
| —— | —— | —— | —— | —— | ||
| -$248.3M-16.8% | -$250.32M+8.2% | -$239.99M+23.2% | -$258.23M-2.1% | -$212.63M+33.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Sana Biotechnology profitable?
- Sana Biotechnology is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months.
- What is Sana Biotechnology's earnings per share?
- Sana Biotechnology's diluted EPS over the trailing twelve months is $-0.93.
- Where does Sana Biotechnology's income statement data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.